Atogepant shows efficacy for prevention of migraine
Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings of… read more.
Atogepant, an oral drug approved in the US for the prevention of episodic migraine treatment appears to also be effective for the prevention of chronic migraine. The findings of… read more.
Even mild concussion can cause long-lasting effects to the brain, according to researchers at the University of Cambridge. Using data from a Europe-wide study, the team has shown… read more.
Researchers at UNSW Sydney and Neuroscience Research Australia (NeuRA) have developed and evaluated a tool for assessing dementia risk, with promising initial results. Currently, over 55 million people are living with dementia… read more.
Exenatide, an injectable treatment for type 2 diabetes, has shown efficacy for the treatment of ‘blinding’ headaches known as idiopathic intercranial hypertension (IIH). Researchers from a phase 2… read more.
People who have low bone density may have an increased risk of developing dementia compared to people who have higher bone density, according to a study published in… read more.
Patients with ‘blinding’ headaches known as Idiopathic Intercranial Hypertension (IIH) could be treated with an injectable peptide used for type 2 diabetes, a new trial has found. The… read more.
The results of the clinical trial of a new wrist device designed to help control the symptoms of Tourette syndrome have shown it significantly reduces the severity and… read more.
Is head injury associated with long-term all-cause mortality risk? Findings from a 30-year follow-up study indicate such an association, researchers reported on Jan 25, 2023 in JAMA Neurology…. read more.
When women suffer migraine attacks, it is often just before or during their monthly period. A team of researchers from Charité – Universitätsmedizin Berlin has now identified a… read more.
New research shows that patients with newly diagnosed type 2 diabetes who received treatment with the diabetes drug pioglitazone were less likely to go on to develop dementia… read more.
Difelikefalin, a drug used to treat itching associated with chronic kidney disease in adults undergoing hemodialysis, shows efficacy for treating notalgia paresthetica, a nerve disorder causing persistent itch… read more.
Parents: It might be time to rethink your family’s video-gaming rules. New research findings challenge the fears parents have been hearing for years that children who spend hour… read more.
Advertisment